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 Recent clonal ocular isolates of Pseudomonas aeruginosa from India have acquired a 30 
number of resistance genes compared to historical clones  31 
 Consequently, resistance to antibiotics particularly fluoroquinolones in recent clones 32 
of P. aeruginosa appears to have increased. 33 
 The acquired resistance genes found in the recent P. aeruginosa isolates were related 34 
to mobile genetic elements. 35 
Abstract 36 
Objectives  37 
This study compared the resistomes of isolates of Pseudomonas aeruginosa clone ST308 38 
from 2018 and 1997 from India.   39 
Methods 40 
Two ocular clonal type ST308 isolates of Pseudomonas aeruginosa (198 and 219) isolated in 41 
2018 and five historical isolates (31, 32, 33, 35 and 37) isolated in 1997 at the LV Prasad Eye 42 
Institute in India were analysed for their susceptibilities to ciprofloxacin, levofloxacin, 43 
gentamicin, tobramycin, piperacillin, imipenem, ceftazidime and polymyxin B. DNA was 44 
extracted using the DNeasy® Blood and Tissue. Paired-end library was prepared using 45 
Nextera XT DNA library preparation kit. Libraries were sequenced on Illumina® MiSeq 46 
bench top sequencer generating 300 bp paired-end reads. Spades v3.12.0 was used for 47 
assembly, Resfinder v3.1. for acquired resistance genes and Snippy V2 for variants calling. 48 
Integron finder v1.5.1 was used to identify the integrons present in the genomes. 49 
Results 50 
 51 
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The recent isolate 219 was resistant to all tested antibiotics except polymyxin while isolate 52 
198 was resistant to ciprofloxacin, levofloxacin, gentamicin and tobramycin. Among 53 
historical isolates five were resistant to gentamicin, tobramycin and ciprofloxacin, four were 54 
resistant to levofloxacin while two were resistant to polymyxin. Twenty-four acquired 55 
resistance genes were present in the 2018 isolates compared to 11 in the historical isolates. 56 
All isolates contained the following genes encoding for aminoglycoside aph(6)-Id, aph(3')-57 
lIb, aph(3'')-Ib), beta-lactam (blaPAO), tetracycline (tet(G)), fosfomycin (fosA), 58 
chloramphenicol (catB7), sulphonamide (sul1), quaternary ammonium (qacEdelta1) and 59 
fluoroquinolone (crpP) resistance. Isolate 198 possessed aph(3')-VI, rmtD2, qnrVC1, 60 
blaOXA-488, blaPME-1, while 219 possessed aadA1, rmtB, aac(6')-Ib-cr, blaTEM-1B, 61 
blaVIM-2, mph(E), mph(A), msr(E). In the isolate 219 genes blaTEM-1b, blaVIM-2, sul1, 62 
qnrvc1, rmtB and aadA1 were carried on class 1 integron. While an incomplete class 1 63 
integron was also found in isolate 198 which was located on the genome where gene rmtB, 64 
blaPME-1, qnrVC1 and sul1 genes were positioned. There were no notable differences in the 65 
number of single nucleotide polymorphisms, but recent isolates carried more insertions and 66 
deletions in their genes.   67 
Conclusion 68 
P. aeruginosa ocular clonal isolates have changed over time, with strains acquiring genes and 69 
having more insertions and deletions in their chromosomal genes that confirm resistance to 70 
antibiotics. 71 
Keywords 72 
DNA extraction, genome sequencing, acquired resistance, single nucleotide polymorphism 73 
  74 
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Pseudomonas aeruginosa causes a variety of infections including lung infections in patients 76 
with cystic fibrosis, skin infections after burns and corneal infections (microbial keratitis). 77 
The increasing prevalence of multidrug resistant (MDR) P. aeruginosa reduces the treatment 78 
options and complicates management of these infections. Antibiotic resistance occurs mainly 79 
due to chromosomal gene mutations and possession of transferrable resistance determinants. 80 
[1] MDR isolates can be clonal, particularly those associated with hospital acquired 81 
infections. [2]  82 
Clones of P. aeruginosa may vary based on the environments [3], and may cause infection 83 
outbreaks when these clones enter a new environment. For example, P. aeruginosa isolated 84 
from water sources can also be isolated from cystic fibrosis patients [4]. Only a few studies 85 
have identified clones of ocular isolates of P. aeruginosa [5, 6]. Five multi-drug resistant P. 86 
aeruginosa isolates from corneal infections have been reported to be clonal and of sequence 87 
type 308. [6] The isolates were collected in 1997 from microbial keratitis cases in India. The 88 
current study investigated the genomes of more recently collected MDR P. aeruginosa 89 
corneal isolates recovered from the same location in India to investigate whether this clonal 90 
variant had persisted and whether it had acquired or lost antibiotic resistance genes. 91 
Materials and methods 92 
P. aeruginosa genomic sequencing  93 
DNA was extracted using DNeasy Blood and Tissue Ki (Qiagen, Hilden Germany) as per the 94 
manufacturer’s recommendations from two keratitis P. aeruginosa strains 198 and 219 95 
isolated in India in 2018. A paired-end library was prepared using Nextera XT DNA library 96 
preparation kit (Illumina, San Diego, CA, USA). All the libraries were multiplexed on one 97 
MiSeq run. The raw reads of the sequenced genomes were analysed for their quality using 98 
FastQC version 0.117 (https://www.bioinformatics.babraham.ac.uk/projects/fastqc). 99 
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Version 0.38 of the Trimmomatic [7] was used for trimming the adapters from the reads 100 
following de-novo assembly using Spades v3.13.0 [8]. Genomes were annotated using Prokka 101 
v1.12 [9]. Sequence types were investigated using PubMLST https://pubmlst.org/. Resistance 102 
genes were identified using online database Resfinder v3.1 (Centre for Genomic 103 
Epidemiology, DTU, Denmark) [10]. Mutations in the genes were detected using Snippy V2 104 
[11] using PAO1 as a reference genome. Core genome and pan genomes were analysed using 105 
Harvest Suite Parsnp v1.2 and Roary v3.11.2 respectively. Integrons were located using 106 
Integron finder v1.5.1. The genes possessed by strains 198 and 219 were then compared to 107 
those from other ST308 isolates that had been previously examined [6]. 108 
Antibiotic resistance 109 
Strains 198 and 219 (isolated in 2018) and five strains isolated in 1997 PA31, PA32, PA33, 110 
PA35 AND PA37 [6] were screened for resistance to a variety of antibiotics which are 111 
commonly used to treat microbial keratitis [12]. The minimum inhibitory concentration 112 
(MIC) and minimum bactericidal concentration (MBC) of ciprofloxacin, levofloxacin, 113 
gentamicin, ceftazidime (Sigma-Aldrich, St. Louis Missouri, USA), polymyxin B (Sigma-114 
Aldrich, Vandtårnsvej, Søborg, Denmark) tobramycin, piperacillin (Cayman Chemical 115 
Company, Ann Arbor, Michigan, USA) and imipenem (LKT Laboratories Inc, Minnesota, 116 
USA) were determined using the broth microdilution method in 96-wells plates following 117 
CLSI guidelines. The concentrations of antibiotics tested ranged from 5120 µg/ml to 0.25 118 
µg/ml. The susceptibility results were interpreted using EUCAST v9 [13] and CLSI [14]  119 
breakpoints for antibiotics.  120 
 121 
Results  122 
 123 
Antibiotic susceptibility and Sequence type analysis 124 
Isolates 198 and 219 had sequence type 308 indicating that these strains were clonally related 125 
to the ST308 strains isolated in 1997 at the same hospital.  126 
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Isolate 219 was resistant to all antibiotics (Table 1) other than polymyxin (MIC= 0.5 µg/ml, 127 
MBC=1 µg/ml). Isolate 198 was resistant to ciprofloxacin, levofloxacin, tobramycin and 128 
gentamicin, and showed intermediate susceptibility to polymyxin (Table 1). The isolates from 129 
1997 were all resistant to gentamicin and tobramycin and showed intermediate or definite 130 
resistance to imipenem (Table 1). All five isolates from 1997 were resistant or had 131 
intermediate resistance to ciprofloxacin and four were resistant to levofloxacin (Table 1). 132 
Two isolates from 1997 showed intermediate resistance to polymyxin (Table 1). Overall, the 133 
MIC and MBC values to ciprofloxacin and levofloxacin of 198 and 219 were higher than 134 
those recorded for the historical isolates (Table 1). 135 
Possession of horizontally-acquired resistance genes  136 
In total 24 acquired resistance genes were present in the ST308 isolates of P. aeruginosa 137 
(Table 2). The isolates from 1997 all possessed the same 11 resistance genes. However, the 138 
isolates from 2018 had acquired additional resistance genes. Isolate 198 carried 15 and 219 139 
carried 20 resistance genes. Ten resistance genes were common to all seven isolates (Table 140 
2). These ten genes were three aminoglycoside resistance genes (aph(6)-Id, aph(3')-lIb, 141 
aph(3'')-Ib), a beta-lactam resistance gene (blaPAO), a tetracycline resistance gene (tet(G)), a 142 
fosfomycin resistance gene ( fosA), a chloramphenicol resistance gene (catB7) a 143 
sulphonamide resistance gene (sul1), and a quaternary ammonium compound resistance gene 144 
(qacEdelta1). The recent isolates lacked one beta lactam gene (blaOXA-50) which was 145 
present in all the historical isolates.  146 
Aminoglycoside resistance genes 147 
Strain 198 had acquired a 16S rRNA methylase gene (rmtD2) carried on class 1 integron and 148 
three aminoglycoside modifying enzyme genes aph(6)-Id, aph(3')-lIb, and aph(3'')-Ib). Strain 149 
219 had acquired three different aminoglycoside resistance genes, a 16S rRNA methylase 150 
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(rmtB), a streptomycin adenylyltransferase gene (aadA1) carried on class 1 integron and an 151 
aminoglycoside acetyltransferase gene (aac(6')-Ib-cr). Strain 219 had also acquired the 152 
plasmid related aminoglycoside and fluoroquinolone resistance gene aac(6')-Ib-cr.  153 
Fluoroquinolones resistance genes 154 
One fluoroquinolone resistance gene, crpP, was present in all isolates from 1997 and 2018. 155 
An integron-related fluoroquinolone resistance gene qnrVC1 was only present in isolates 156 
from 2018 (Table 1) and was carried on class 1 integron on both isolates 198 and 219. The 157 
plasmid related aminoglycoside and fluoroquinolone resistance gene aac(6')-Ib-cr was found 158 
in strain 219 and this strain had higher MICs for ciprofloxacin and levofloxacin compared to 159 
strain 198 and the 1997 isolates. 160 
Beta-lactam resistance genes 161 
The metallo-beta-lactamase gene class B metallo-b-lactamase blaVIM-2 and a transposon 162 
(Tn2) encoded gene blaTEM-1B had been acquired by isolate 219 and were carried on class 1 163 
integron. An extended spectrum plasmid-related class A beta lactamase gene blaPME-1 had 164 
been acquired by 198 and were carried on class 1 integron. A class-D beta lactamase gene 165 
blaOXA-488 had been acquired by both 198 and 219.  166 
Non-synonymous mutations in the ST308 resistome 167 
Table 3 details the non-synonymous mutations leading to changes in the nucleic acid 168 
sequence in the resistance genes of these P. aeruginosa isolates, including those related to 169 
efflux pumps, antibiotic-inactivating enzymes and drug target alterations. These non-170 
synonymous mutations were made in comparison to the reference genome of strain PAO1. 171 
The number of mutations in almost all of the genes remained same in the 1997 and 2018 172 
isolates. However, the efflux pump gene opmH contained 10 SNPs in the isolates from 2018, 173 
but only 1-5 SNPS in the isolates from 1997 (Table 3). Similarly, oprD also contained 8 174 
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SNPs in the two 2018 isolates. Furthermore, non-synonymous insertions/deletions [15] and 175 
frame-shift mutations were found in the two isolates from 2018 (Table 4) whereas the ST308 176 
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µg/ml ≤1,2, ≥4  
Levofloxacin 
µg/ml ≤2, 4, 
≥8 
Gentamicin µg/ml 
≤4, 8, ≥16  
Tobramycin µg/ml 





µg/ml ≤2, 4, 
≥8 
Ceftazidime 





MIC  MBC  MIC  MBC  MIC  MBC  MIC  MBC  MIC  MBC MIC  MBC  MIC  MBC  MIC  MBC  
198 1280 (R) 2560 320 (R) 1280 2560 (R) 5120 16 (R) 16 8 8 1 2 8 8 4 (I) 4 
219 ≥5120 (R) ≥5120 640 (R) 1280 ≥5120 (R) ≥5120 1280 (R) 2560 2560 (R) 5120 32 (R) 64 16 (I) 32 0.25 1 
31 32 (R) 64 32 (R) 32 5120 (R) 5120  640 (R)  1280 4 8 4 (I) 16 16 (I) 32 4 (I) 4 
32 64 (R) 128 32 (R) 32 2560 (R) 5120  640 (R) 1280 16 32 4 (I) 4 16 (I) 16 4 (I) 16 
33 128 (R) 128 32 (R) 64 2560 (R) 5120 ≥5120 (R) ≥5120  32 (R) 64 8 (R) 16 32 (R) 64 2 4 
35 2 (I) 4 2 4 2560 (R) 2560 1280 (R) 2560  8 16 16 (R) 16 4 8 2 2 
37 64 (R) 128 32 (R) 32 2560 (R) 2560 1280 (R) 2560  8  16  8 (R) 8 16 (I) 64 2 4 
P. aeruginosa isolates in the light shade are recent and those with dark shading are historical isolates. MIC and MBC values of historical isolates 197 
were included from previously published data [6] for all antibiotics except tobramycin and piperacillin. MICs and MBCs of these two antibiotics 198 
for the historical isolates and all antibiotics for the recent isolates have been are examined in this study.  199 
 200 
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  201 





198 219 31 32 33 35 37 
Amino- 
glycoside  
aph(6)-Id        
aph(3')-VI        
aph(3')-lIb        
aph(3'')-Ib        
aadA1        
rmtD2        






       
Fluoroquinolone 
crpP        




       
blaPAO        
blaOXA-50        
blaTEM-1B        
blaVIM-2        




qacEdelta1        
Sulphonamide sul1        
Tetracycline tet(G)        
Macrolide 
mph(E)        
mph(A)        
Macrolide,  
Lincosamide and 
Streptogramin B  
msr(E)        
Chloramphenicol catB7        
Fosfomycin fosA        




  207 
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Table 3.  Single nucleotide polymorphism due to non-synonymous mutations in the genes of 208 





























31 32 33 35 37 198 219 




PA0157 triB  0  0 1 0   0  0 0  




PA0424 mexR 2 1 1 1 1 1 1 




PA1236 farB 1 1 1 1 1 1 1 




PA1316 lrfA 2 2 2 2 2 2 2 
PA1435 mexM 4 4 4 4 4 4 4 
PA1436 mdtC 2 2 2 2 2 2 2 
PA2018 mexY 5 5 5 5 5 5 
* 5 
* 
PA2019 mexX 4 4 4 4 4 4 4 
PA2389 macA 2 1 1 1 1 1 1 
PA2390 macB 1 1 1 1 1 1 1 




PA2491 mexS 2 2 2 2 2 2 2 
PA2495 oprN 1 1 1 1 1 1 1 
PA2837 opmA 3 3 3 3 3 3 3 
PA3019 taeA 1 1 1 1 1 1 1 
PA3137 farB 1 1 1 1 1  0  0 




PA3522 mexQ 4 4 4 4 4 4 4 
PA3523 mexP 2 2 2 2 2 2 2 
PA3676 mexK 1 1 1 1 1 1 1 
PA3677 mexJ 2 2 2 2 2 2 2 
PA3678 mexL 1 1 1 1 1 1 1 
PA4205 mexG 1 1 1 1 1 1 1 
PA4206 mexH 1 1 1 1 1 1 1 
PA4207 mexI 1 1 1 1 1 2 1 




PA4374 mexV 2 2 2 2 2 2 2 
PA4375 mexW 2 2 2 2 2 2 2 
PA4598 mexD 2 2 2 2 2 2 2 
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PA4990 emrE 1 1 1 1 2 1 1 








PA5160 farB 4 3 3 4 3 3 3 
PA5518 rosB 3 3 3 3 3 2 2 




4 4 4 4 4 4 4 











2 2 2 2 2 
2 2 
PA5514 OXA-50 1 2   3 2 2 2 






1 1 1 1 1 1 1 
PA1972 pmrC 3 3 3 3 3 3 3 
PA3002 mfd 1 2 2 2 2 2 2 
PA3168 gyrA 1 1 1 1 1 1 1 




PA4265 tufA 1  0  0 0  1 0  0  
PA4560 ileS 2 2 2 2 2 3 2 
PA4964 parC 2 2 2 2 2 2 2 
PA4967 parE 1 1 1 1 1 1 1 




PA0920 mprF 6 6 6 6 6 6 6 












PA2020 mexZ 0  1 1 1 1 1 1 
(*) represents insertions or deletions in the genes, (†) represents frame-shift mutations in the 210 
genes 211 
 212 









PA0156 triA 2 2 
PA0158 triC 2 1  
PA0426 mexB 1  1 
PA1282 lrfA 2 2 
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Phylogeny of ST308 isolates 217 
The genomes of these ST308 isolates were aligned using PAO1 as a reference for the core 218 
genome and pangenome phylogeny. In the core genome phylogenetic analysis, all the isolates 219 
were clustered together in a single group. The number of core genes and total genes were 220 
same for all isolates except isolate 219 which had a larger number of total genes but a similar 221 
number of core genes to all other isolates (Table 5). 222 
Table 5. Number of genes present in Core and pan genomes of P. aeruginosa isolates. 223 
P. aeruginosa isolates Core genes Total genes 
31 5445 6937 
32 5447 6927 
33 5440 6932 
35 5442 6932 
37 5450 6958 
198 5454 6882 




PA2018 mexY 1 1 
PA2391 opmQ 3 3 
PA3521 opmE 1 1 
PA4208 opmD 1 1 
PA4599 mexC 1 1 
PA4974 opmH 7 8 
PA4997 msbA 2 2 
PA5518 adeC 1 1 
PA4109 ampR 1 1 
PA4110 ampC 2 2 
PA3946 rosC 1 1 
PA3554 arnA 2 2 
PA0958 oprD 6 6 
PA2492 mexT 1Frame-shift deletion 1Frame-shift deletion 
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Discussion          227 
This study examined whether the resistome of the ST308 clone of ocular isolates of P. 228 
aeruginosa had changed over time. Previously, P. aeruginosa ST308 clones had been 229 
reported as multidrug-resistant isolates of nosocomial [16] ocular [6] and canine origin [17]. 230 
For the P. aeruginosa isolates from three different sources the MIC to imipenem was high 231 
which was similar to the finding in the ocular isolates of P. aeruginosa in the present study. 232 
The ocular isolates of clone ST308 from 2018 had acquired additional resistance genes and 233 
had changes in the mutational patterns of the resistance genes compared to ocular isolates 234 
from 1997.  235 
Two different variants of 16S rRNA methylase, rmtD2 and rmtB, related to aminoglycoside 236 
resistance were found in the 2018 isolates. These genes have not been reported previously in 237 
ST308 but other variants of the same genes have been identified in clones ST316 and ST235 238 
[18] the latter clone being identified as a widespread multi-drug resistance clone. The 239 
presence of a larger group of beta lactam resistance genes, specifically those acquired on 240 
mobile genetic elements including class A and B metallo-beta lactam genes including 241 
blaTEM-1B, blaVIM-2, blaPME-1 carried on integron is a unique finding related to ST308 in 242 
the current study. These beta lactam resistance genes have not been reported previously in 243 
strains of this clone [6]. However, the possession of sul1 gene in isolates of present study was 244 
similar to the similar ST308 found previously [17]. The possession of blaVIM-2 and blaTEM-245 
1B may have been responsible for the high MIC to piperacillin and imipenem of PA219. 246 
Previously, these genes were associated to increased MIC of imipenem and 247 
piperacillin/tazobactam in P. aeruginosa isolates [19]. 248 
  249 
Metallo-beta lactam genes are usually found on class-1 integrons along with other antibiotic 250 
resistance determinants [20] which is similar to the present study but identification of class 1 251 
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integron carrying resistance genes in the ocular P. aeruginosa isolates is a novel finding. 252 
These metallo-beta lactam genes are easily transmissible on mobile genetic elements such as 253 
transposons, plasmid-integrative conjugative elements and genomic islands. These metallo-254 
beta lactam genes (blaTEM-1B, blaVIM-2, blaPME-1) have not been previously reported in 255 
ST308 but have been found in ST111 and ST235 [21] [22]. Although different variants of 256 
these genes were found in the similar ST308 before [16, 17]. Acquired genes within the 257 
mobile genetic elements of ST308 clones were not been identified in an earlier report [6]. 258 
Both recent isolates 198 and 219 had acquired genes associated with mobile genetic elements 259 
in the current study.  260 
The presence of the plasmid related fluoroquinolone resistance gene qnrVC1 [23] and the 261 
recently reported plasmid related gene crpP [24] are also novel findings in the current study 262 
related to clonal ST308 P. aeruginosa isolates. All isolates contained the fluoroquinolone 263 
resistance gene crpP, but this had not been identified as a potential plasmid related 264 
fluoroquinolone resistance gene prior to the publication of resistance genes of the 1997 265 
isolates [6]. Usually fluoroquinolone resistance is due to mutation in DNA gyrase and 266 
topoisomerase IV genes [25]. However, in the 2018 isolates of ST308 very high MICs to 267 
ciprofloxacin and levofloxacin might be due to the acquisition of qnrVC1. Strain 219 had also 268 
acquired the plasmid related fluoroquinolone resistance gene aac(6')-Ib-cr [26] which can 269 
confer resistance to both fluoroquinolones and aminoglycosides [27]. Previously this gene 270 
was found responsible for the 16 to 128-fold higher MICs for ciprofloxacin in the 271 
transconjugants bacteria of family Enterobacteriaceae [28] and MIC of 64 µg/ml of  272 
ciprofloxacin to MDR P. aeruginosa isolates [29]. These additional resistance imposing 273 
elements to fluoroquinolones suggest that alternative treatments for keratitis other than 274 
fluoroquinolone monotherapy should be considered. Acquisition of larger number of 275 
aminoglycoside and beta lactam resistance genes is alarming because, where first line therapy 276 
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such as monotherapy with fluoroquinolones fails, fortified antibiotics [30] such as gentamicin 277 
plus cephalosporins are often prescribed.  278 
Among all the P. aeruginosa isolates, the core genome was composed of almost similar 279 
number of genes which was perhaps indicative of the collinear nature of conserved genome 280 
of P. aeruginosa isolates .[31, 32]  However, a larger pan genome of isolate 219 indicates 281 
greater genomic diversity due to acquisition of genes from the same or different species or 282 
genera. This fact might relate to the larger number of acquired genes in isolate 219 by 283 
horizontal gene transfer. [31]  Identification of indels (insertion/deletion polymorphisms due 284 
to non-synonymous mutations) in the 2018 keratitis isolates of P. aeruginosa which were not 285 
present in the strains isolated in 1997 [6] as well as the increased presence of certain SNPs 286 
suggest that there was an increase in selection pressure in the environment that has selected 287 
for these mutations.  288 
Increases in the resistance of keratitis isolates to the fluoroquinolone moxifloxacin have been 289 
associated with an increase in average diameter of the infiltrate or scar, a slower time to re-290 
epithelialization and decrease in final visual acuity. [33, 34] Therefore, the findings from the 291 
current study showing that strains of P. aeruginosa, at least in this Indian environment, have 292 
gained additional resistance genes and higher levels of resistance suggests that treatment of 293 
keratitis might be becoming more problematic.  294 
Nucleotide accession 295 
The nucleotide sequences are available in the GenBank under the Bio project accession 296 
number PRJNA590804. 297 
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